Study Sponsor:
Children's Oncology Group
Full IRB Study Title:
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-trans Retinoic Acid
If you are interested in this study or have questions about your child's eligibility, please contact:
Rebecca D. Considine Research Institute,
330-543-3193 or email
research@akronchildrens.org